OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Catch up on who has new jobs and recognitions that companies have received.
The Duke Clinical Research Institute has named Frank Rockhold, PhD, as professor of biostatistics and bioinformatics. Rockhold was most recently senior vice president of Global Clinical Safety and Pharmacovigilance at GlaxoSmithKline, and prior to that ran Cardiovascular and Metabolic Development and the Biostatistics, Epidemiology and Healthcare Informatics departments.
Bioclinica has added two global executive-level to its eHealth Systems team--Steven Herne, chief commercial officer and Francois Audibert, vice president for global consulting. Herne was most recently chief commercial officer at ERT and previously was senior vice president, global business development at ICON. Audibert will lead Bioclinica's global consulting practice specializing in data sciences, safety system and process and will head the Company's life sciences big data strategy. Audibert was most recently vice president of pharmacovigilance at HighPoint Solutions, and prior to this was safety solutions director at Oracle.
The European Patients’ Forum (EPF) has made the following placements:
Marco Greco has been elected as President of the EPF. EPF immediate past President, Anders Olauson, has been awarded the title of Honorary President. The Board also added two new members, Michal Rataj from the European Alliance of Neuromuscular Disorders Associations, and Juan Fuertes, from Pulmonary Hypertension Association Europe (PHA Europe). Three members of the Board have been re-elected for a new two year term: Brian West (European Aids Treatment Group, EATG) who was elected by the board as Vice President, Dominik Tomek (AOPP, Slovakian Patients’ Coalition) and Susanna Palkonen (European Federation of Allergies and Airways Diseases Association, EFA).
WIRB-Copernicus Group® (WCG™) has assembled its WCG Gene Therapy™ Advisory Board to advise the company regarding the latest advances in gene therapy research. Members include Mark Bagarazzi, MD, chief medical officer at Inovio Pharmaceuticals, and past director of regulatory worldwide affairs at Merck; Carl June, MD, director of the Translational Research Program and professor of immunotherapy at Penn Medicine, and chair of the American Society of Gene and Cell Therapy’s (ASGCT’s) Cancer Vaccines Committee; and Hans-Peter Kiem, MD, Dr. med., professor at the University of Washington (UW) School of Medicine, associate head of the Heme Malignancy Program for the UW/Fred Hutchinson Cancer Consortium, chair of the National Institutes of Health Recombinant DNA Advisory Committee, and chair of ASGCT Stem Cell Center; Arnold J. Levine, PhD, professor of the Institute for Advanced Study at the School of Natural Sciences at Princeton University, and professor in the pediatrics and biochemistry departments at the Robert Wood Johnson Medical Center; and Tony Reid, MD, PhD, professor of medicine, hematology/oncology at the Moores Cancer Center and director of early phase clinical investigation at UC San Diego, and chairman of the Association of American Cancer Institutes’ Clinical Research Initiative.
PPD has named Hacene Mekerri vice president of its central laboratory organization. Mekerri most recently served as managing director for the Asia Pacific region of a large CRO, as well as global director of data management and country head for a global central laboratory focused on late stage clinical trials.
PPD also appointed Panteli Theocharous, FIBMS, PhD, FRCPath, as vice president of global product development in the hematology/oncology therapeutic area. Theocharous most recently served as vice president and head of clinical and medical affairs at Cell Therapeutics, Inc., Life Sciences in London.
ERT has received Omega Management Group’s NorthFace ScoreBoard (NFSB) Award for consistently delivering outstanding customer service in 2015. This marks the fourth consecutive year that ERT has been recognized for achieving excellence in customer satisfaction, as rated solely by its customers.
Veeva was listed in Forbes magazine as a best software company to work for in 2015. The ranking was based on analysis of third-party ratings of global software companies featured in Software Magazine’s Software 500 list. Also, with revenue growth of 621% from 2011 to 2014, Veeva was ranked 139 in Deloitte’s 2015 Technology Fast 500 survey of North America’s fastest-growing technology, media, telecommunications, life sciences, and energy technology companies.
Parexel has been named to Forbes magazine’s America’s “Best Employers” list for 2016.
Exco InTouch was recognized as the sixth fastest growing technology company in the North of England and Scotland in the 2016 Northern Tech Awards, and was presented with the Judges’ Award for International Success.
goBalto has earned a spot on the 20 Most Promising Biotech Technology Solution Providers list of 2016 by CIOReview Magazine. The award selection by honorary industrial experts is based on evaluation of goBalto's specialties in helping clinical trial sponsors and clinical research organizations (CRO) optimize study startup processes.
Target Health has been selected to receive the Small Business Global Award by the City of New York.